Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tandem Mass Spectrometry | 9 | 2023 | 173 | 3.760 |
Why?
|
| Chromatography, Liquid | 6 | 2023 | 140 | 1.360 |
Why?
|
| Nanoparticles | 3 | 2022 | 294 | 1.340 |
Why?
|
| Rats | 15 | 2022 | 3261 | 1.030 |
Why?
|
| Nanomedicine | 3 | 2021 | 32 | 1.030 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2021 | 406 | 0.950 |
Why?
|
| Copper Radioisotopes | 3 | 2012 | 8 | 0.920 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 756 | 0.900 |
Why?
|
| Gold | 6 | 2012 | 134 | 0.890 |
Why?
|
| Reproducibility of Results | 8 | 2023 | 901 | 0.860 |
Why?
|
| Plasma | 1 | 2022 | 29 | 0.840 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2012 | 176 | 0.770 |
Why?
|
| Aminopyridines | 1 | 2020 | 13 | 0.770 |
Why?
|
| Oxyquinoline | 1 | 2020 | 5 | 0.760 |
Why?
|
| Mycophenolic Acid | 1 | 2019 | 7 | 0.740 |
Why?
|
| Tongue | 1 | 2019 | 11 | 0.740 |
Why?
|
| Communicable Diseases | 1 | 2020 | 42 | 0.710 |
Why?
|
| Animals | 23 | 2023 | 14307 | 0.690 |
Why?
|
| Chloroquinolinols | 1 | 2018 | 3 | 0.680 |
Why?
|
| Tissue Distribution | 5 | 2020 | 197 | 0.650 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 396 | 0.640 |
Why?
|
| Anilides | 2 | 2017 | 27 | 0.560 |
Why?
|
| Cyclohexanes | 2 | 2017 | 29 | 0.550 |
Why?
|
| Nanoshells | 2 | 2012 | 2 | 0.540 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2014 | 65 | 0.540 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2021 | 1534 | 0.520 |
Why?
|
| Itraconazole | 1 | 2013 | 12 | 0.490 |
Why?
|
| Nanospheres | 1 | 2013 | 7 | 0.490 |
Why?
|
| Polyglycolic Acid | 1 | 2013 | 35 | 0.480 |
Why?
|
| Positron-Emission Tomography | 2 | 2012 | 79 | 0.470 |
Why?
|
| Head and Neck Neoplasms | 2 | 2012 | 73 | 0.460 |
Why?
|
| Lactic Acid | 1 | 2013 | 87 | 0.460 |
Why?
|
| Drug Carriers | 1 | 2013 | 121 | 0.440 |
Why?
|
| Neoplasms | 1 | 2022 | 1033 | 0.440 |
Why?
|
| Chromans | 1 | 2012 | 15 | 0.430 |
Why?
|
| Linear Models | 3 | 2019 | 253 | 0.430 |
Why?
|
| Antifungal Agents | 1 | 2013 | 147 | 0.430 |
Why?
|
| Vitamin E | 1 | 2012 | 56 | 0.420 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2011 | 12 | 0.400 |
Why?
|
| Peptides, Cyclic | 1 | 2011 | 30 | 0.390 |
Why?
|
| Drug Delivery Systems | 2 | 2022 | 182 | 0.370 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 55 | 0.370 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1300 | 0.360 |
Why?
|
| Nanotechnology | 4 | 2005 | 150 | 0.340 |
Why?
|
| Gold Colloid | 3 | 2005 | 5 | 0.330 |
Why?
|
| Sensitivity and Specificity | 3 | 2023 | 555 | 0.310 |
Why?
|
| Rats, Nude | 3 | 2012 | 6 | 0.310 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 180 | 0.310 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 2128 | 0.300 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 45 | 0.300 |
Why?
|
| Peptides | 3 | 2005 | 308 | 0.300 |
Why?
|
| Light | 1 | 2007 | 180 | 0.280 |
Why?
|
| Drug Stability | 2 | 2018 | 110 | 0.270 |
Why?
|
| Male | 9 | 2020 | 18870 | 0.260 |
Why?
|
| Mice | 6 | 2023 | 5668 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 242 | 0.260 |
Why?
|
| 2,2'-Dipyridyl | 1 | 2003 | 6 | 0.240 |
Why?
|
| Injections, Intralesional | 2 | 2014 | 11 | 0.240 |
Why?
|
| Biological Availability | 2 | 2021 | 84 | 0.230 |
Why?
|
| Solubility | 2 | 2021 | 115 | 0.230 |
Why?
|
| Humans | 13 | 2022 | 34853 | 0.220 |
Why?
|
| Injections, Intravenous | 2 | 2013 | 58 | 0.220 |
Why?
|
| Doxorubicin | 1 | 2022 | 80 | 0.210 |
Why?
|
| Microsomes, Liver | 1 | 2022 | 69 | 0.210 |
Why?
|
| Liposomes | 1 | 2022 | 107 | 0.210 |
Why?
|
| Hydrazones | 1 | 2020 | 5 | 0.200 |
Why?
|
| Transplantation, Heterologous | 2 | 2011 | 87 | 0.190 |
Why?
|
| Feasibility Studies | 2 | 2012 | 196 | 0.190 |
Why?
|
| Chemistry, Physical | 1 | 2020 | 44 | 0.190 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 61 | 0.190 |
Why?
|
| Thermodynamics | 1 | 2020 | 207 | 0.170 |
Why?
|
| Neutron Activation Analysis | 2 | 2010 | 2 | 0.170 |
Why?
|
| Heart | 1 | 2020 | 178 | 0.160 |
Why?
|
| Molecular Structure | 1 | 2020 | 467 | 0.160 |
Why?
|
| Mice, SCID | 2 | 2017 | 143 | 0.160 |
Why?
|
| Protein Binding | 3 | 2017 | 913 | 0.160 |
Why?
|
| Kidney | 1 | 2020 | 322 | 0.160 |
Why?
|
| Serum Albumin, Bovine | 4 | 2004 | 49 | 0.150 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2017 | 41 | 0.150 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2017 | 28 | 0.150 |
Why?
|
| Particle Size | 3 | 2007 | 200 | 0.140 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 122 | 0.140 |
Why?
|
| Cell Nucleus | 3 | 2017 | 351 | 0.140 |
Why?
|
| Pharmaceutical Solutions | 1 | 2014 | 5 | 0.130 |
Why?
|
| Proline | 1 | 2014 | 37 | 0.130 |
Why?
|
| Freeze Drying | 1 | 2013 | 25 | 0.120 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 6 | 0.120 |
Why?
|
| Delayed-Action Preparations | 1 | 2013 | 57 | 0.120 |
Why?
|
| Solvents | 1 | 2013 | 93 | 0.120 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 124 | 0.110 |
Why?
|
| Curcumin | 1 | 2013 | 66 | 0.110 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 129 | 0.100 |
Why?
|
| Tomography, Emission-Computed | 1 | 2011 | 7 | 0.100 |
Why?
|
| Hyperthermia, Induced | 1 | 2011 | 17 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 206 | 0.100 |
Why?
|
| Laser Therapy | 1 | 2011 | 30 | 0.100 |
Why?
|
| Models, Animal | 1 | 2011 | 131 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2014 | 1349 | 0.100 |
Why?
|
| Hot Temperature | 1 | 2011 | 120 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 114 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2011 | 323 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 445 | 0.090 |
Why?
|
| Octoxynol | 1 | 2007 | 18 | 0.080 |
Why?
|
| Spectrophotometry | 2 | 2004 | 71 | 0.080 |
Why?
|
| Calibration | 1 | 2007 | 55 | 0.080 |
Why?
|
| Cattle | 2 | 2004 | 472 | 0.070 |
Why?
|
| Nuclear Localization Signals | 1 | 2004 | 14 | 0.060 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2003 | 3 | 0.060 |
Why?
|
| Fluorescamine | 1 | 2003 | 3 | 0.060 |
Why?
|
| Flocculation | 1 | 2003 | 6 | 0.060 |
Why?
|
| Succinimides | 1 | 2003 | 9 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 1124 | 0.060 |
Why?
|
| Rhodamines | 1 | 2003 | 20 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2003 | 103 | 0.060 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2003 | 94 | 0.060 |
Why?
|
| Coordination Complexes | 1 | 2003 | 27 | 0.060 |
Why?
|
| Sulfhydryl Compounds | 1 | 2003 | 46 | 0.060 |
Why?
|
| Nanostructures | 1 | 2005 | 133 | 0.060 |
Why?
|
| Glutathione | 1 | 2003 | 160 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2003 | 97 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 196 | 0.060 |
Why?
|
| Glucuronidase | 1 | 2022 | 14 | 0.050 |
Why?
|
| Ligands | 1 | 2003 | 317 | 0.050 |
Why?
|
| Glucuronides | 1 | 2022 | 10 | 0.050 |
Why?
|
| Microsomes | 1 | 2022 | 52 | 0.050 |
Why?
|
| Kinetics | 1 | 2003 | 650 | 0.050 |
Why?
|
| Protein Transport | 2 | 2017 | 286 | 0.050 |
Why?
|
| Electron Transport | 1 | 2001 | 38 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2001 | 81 | 0.050 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2017 | 10 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 161 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 164 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 203 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 859 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 650 | 0.030 |
Why?
|
| Polysorbates | 1 | 2013 | 10 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 20 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 240 | 0.030 |
Why?
|
| Hela Cells | 2 | 2005 | 344 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 80 | 0.030 |
Why?
|
| Female | 2 | 2014 | 19873 | 0.030 |
Why?
|
| Ethanol | 1 | 2013 | 188 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 292 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 781 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 19 | 0.020 |
Why?
|
| Polylysine | 1 | 2004 | 8 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2004 | 58 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2004 | 25 | 0.020 |
Why?
|
| Gene Products, tat | 1 | 2004 | 34 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 86 | 0.020 |
Why?
|
| Metals | 1 | 2004 | 95 | 0.010 |
Why?
|
| Axons | 1 | 2004 | 106 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 296 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 383 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 275 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 480 | 0.010 |
Why?
|
| Enzymes, Immobilized | 1 | 2001 | 13 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2001 | 31 | 0.010 |
Why?
|
| Hippocampus | 1 | 2004 | 546 | 0.010 |
Why?
|
| Catalase | 1 | 2001 | 106 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 9642 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 1442 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1490 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 11034 | 0.010 |
Why?
|
| Neurons | 1 | 2004 | 1130 | 0.010 |
Why?
|